Medical - Pharmaceuticals
Compare Stocks
2 / 10Stock Comparison
ATAI vs DBVT
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
ATAI vs DBVT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Pharmaceuticals | Biotechnology |
| Market Cap | $1.00B | $1721.78T |
| Revenue (TTM) | $3M | $0.00 |
| Net Income (TTM) | $-154M | $-168M |
| Gross Margin | -259.1% | — |
| Operating Margin | -34.6% | — |
| Total Debt | $25M | $22M |
| Cash & Equiv. | $18M | $194M |
ATAI vs DBVT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 21 | May 26 | Return |
|---|---|---|---|
| Atai Beckley N.V (ATAI) | 100 | 22.5 | -77.5% |
| DBV Technologies S.… (DBVT) | 100 | 36.8 | -63.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ATAI vs DBVT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ATAI carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth -1.9%, EPS growth -272.0%, 3Y rev CAGR -75.3%
- -46.9% 10Y total return vs DBVT's -86.8%
- -1.9% revenue growth vs DBVT's -100.0%
DBVT is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 1.26
- Lower volatility, beta 1.26, Low D/E 12.8%, current ratio 3.67x
- Beta 1.26, current ratio 3.67x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -1.9% revenue growth vs DBVT's -100.0% | |
| Quality / Margins | 0.3% margin vs ATAI's -51.1% | |
| Stability / Safety | Beta 1.26 vs ATAI's 1.48, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +202.2% vs DBVT's +114.1% | |
| Efficiency (ROA) | -64.3% ROA vs DBVT's -89.0% |
ATAI vs DBVT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ATAI vs DBVT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
DBVT leads this category, winning 1 of 1 comparable metric.
Income & Cash Flow (Last 12 Months)
ATAI and DBVT operate at a comparable scale, with $3M and $0 in trailing revenue.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $3M | $0 |
| EBITDAEarnings before interest/tax | -$103M | -$112M |
| Net IncomeAfter-tax profit | -$154M | -$168M |
| Free Cash FlowCash after capex | -$90M | -$151M |
| Gross MarginGross profit ÷ Revenue | -2.6% | — |
| Operating MarginEBIT ÷ Revenue | -34.6% | — |
| Net MarginNet income ÷ Revenue | -51.1% | — |
| FCF MarginFCF ÷ Revenue | -29.9% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | +17.7% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -75.0% | +91.5% |
Valuation Metrics
Evenly matched — ATAI and DBVT each lead in 1 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.0B | $1721.78T |
| Enterprise ValueMkt cap + debt − cash | $1.0B | $1721.78T |
| Trailing P/EPrice ÷ TTM EPS | -4.48x | -0.76x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 3255.27x | — |
| Price / BookPrice ÷ Book value/share | 5.73x | 0.66x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
Evenly matched — ATAI and DBVT each lead in 4 of 8 comparable metrics.
Profitability & Efficiency
ATAI delivers a -96.4% return on equity — every $100 of shareholder capital generates $-96 in annual profit, vs $-130 for DBVT. DBVT carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to ATAI's 0.21x. On the Piotroski fundamental quality scale (0–9), DBVT scores 4/9 vs ATAI's 2/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -96.4% | -130.2% |
| ROA (TTM)Return on assets | -64.3% | -89.0% |
| ROICReturn on invested capital | -45.0% | — |
| ROCEReturn on capital employed | -50.4% | -145.7% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 |
| Debt / EquityFinancial leverage | 0.21x | 0.13x |
| Net DebtTotal debt minus cash | $7M | -$172M |
| Cash & Equiv.Liquid assets | $18M | $194M |
| Total DebtShort + long-term debt | $25M | $22M |
| Interest CoverageEBIT ÷ Interest expense | -68.93x | -189.82x |
Total Returns (Dividends Reinvested)
ATAI leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DBVT five years ago would be worth $3,344 today (with dividends reinvested), compared to $2,097 for ATAI. Over the past 12 months, ATAI leads with a +202.2% total return vs DBVT's +114.1%. The 3-year compound annual growth rate (CAGR) favors ATAI at 27.5% vs DBVT's 6.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +7.8% | +5.5% |
| 1-Year ReturnPast 12 months | +202.2% | +114.1% |
| 3-Year ReturnCumulative with dividends | +107.5% | +20.4% |
| 5-Year ReturnCumulative with dividends | -79.0% | -66.6% |
| 10-Year ReturnCumulative with dividends | -46.9% | -86.8% |
| CAGR (3Y)Annualised 3-year return | +27.5% | +6.4% |
Risk & Volatility
DBVT leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
DBVT is the less volatile stock with a 1.26 beta — it tends to amplify market swings less than ATAI's 1.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DBVT currently trades 76.8% from its 52-week high vs ATAI's 61.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.48x | 1.26x |
| 52-Week HighHighest price in past year | $6.75 | $26.18 |
| 52-Week LowLowest price in past year | $1.29 | $7.53 |
| % of 52W HighCurrent price vs 52-week peak | +61.8% | +76.8% |
| RSI (14)Momentum oscillator 0–100 | 46.6 | 43.8 |
| Avg Volume (50D)Average daily shares traded | 6.0M | 253K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates ATAI as "Buy" and DBVT as "Buy". Consensus price targets imply 187.8% upside for ATAI (target: $12) vs 130.5% for DBVT (target: $46).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $12.00 | $46.33 |
| # AnalystsCovering analysts | 4 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
DBVT leads in 2 of 6 categories (Income & Cash Flow, Risk & Volatility). ATAI leads in 1 (Total Returns). 2 tied.
ATAI vs DBVT: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is ATAI or DBVT a better buy right now?
Analysts rate Atai Beckley N.
V (ATAI) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — ATAI or DBVT?
Over the past 5 years, DBV Technologies S.
A. (DBVT) delivered a total return of -66. 6%, compared to -79. 0% for Atai Beckley N. V (ATAI). Over 10 years, the gap is even starker: ATAI returned -46. 9% versus DBVT's -86. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — ATAI or DBVT?
By beta (market sensitivity over 5 years), DBV Technologies S.
A. (DBVT) is the lower-risk stock at 1. 26β versus Atai Beckley N. V's 1. 48β — meaning ATAI is approximately 18% more volatile than DBVT relative to the S&P 500. On balance sheet safety, DBV Technologies S. A. (DBVT) carries a lower debt/equity ratio of 13% versus 21% for Atai Beckley N. V — giving it more financial flexibility in a downturn.
04Which is growing faster — ATAI or DBVT?
On earnings-per-share growth, the picture is similar: Atai Beckley N.
V grew EPS -272. 0% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — ATAI or DBVT?
DBV Technologies S.
A. (DBVT) is the more profitable company, earning 0. 0% net margin versus -484. 6% for Atai Beckley N. V — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DBVT leads at 0. 0% versus -333. 4% for ATAI. At the gross margin level — before operating expenses — ATAI leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — ATAI or DBVT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is ATAI or DBVT better for a retirement portfolio?
For long-horizon retirement investors, DBV Technologies S.
A. (DBVT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 26)). Both have compounded well over 10 years (DBVT: -86. 8%, ATAI: -46. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between ATAI and DBVT?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.